MELPHALAN THERAPY IN MYELOMATOSIS

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

MELPHALAN THERAPY IN MYELOMATOSIS

Abstract

References

Case of multiple myeloma complicated by agranulocytosis

Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria

Treatment of multiple myeloma with urethan; experience with 66 cases over a 2 1/2 year period

Citations

Peptichemio induction therapy in myelomatosis

Skeletal surveys in multiple myeloma. Radiologic-clinical correlation

Acute renal failure in multiple myeloma

MELPHALAN IN THE TREATMENT OF MYELOMATOSIS

Pulmonary fibrosis following therapy with Melphalan for multiple myeloma

Multiple myeloma: development of plasma cell sarcoma during apparently successful chemotherapy

The management of myelomatosis

Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis

Multiple myeloma--complete remission with high dose melphalan chemotherapy

Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma

Pulmonary hyalinizing granulomas in a patient with malignant lymphoma, with development nine years later of multiple myeloma and systemic amyloidosis

Intravenous urethane (ethyl carbamate) therapy of multiple myeloma. From the acute leukemia group B

Update on second primary malignancies in multiple myeloma: a focused review

THE CHEMOTHERAPY OF MALIGNANT DISEASE--PRACTICAL AND EXPERIMENTAL CONSIDERATIONS

Intermittent melphalan and prednisolone therapy in plasma cell myeloma

Alkeran (Melphalan) in the treatment of myelomatosis

Plasmocytoma as a neurosurgical clinical picture

The disease, myelomatosis

The management of myelomatosis

The plasma cells of the bone marrow in myelomatosis treated with Alkeran (melphalan)

Melphalan (L-phenylalanine nitrogen mustard) treatment in myelomatosis. Report of 46 cases

Related Concepts

Related Feeds

Cell Aging (Keystone)

Related Papers

Melphalan (L-phenylalanine nitrogen mustard) treatment in myelomatosis. Report of 46 cases

MELPHALAN IN THE TREATMENT OF MYELOMATOSIS

Ancillary measures in treatment of myeloma. Use of immune serum globulin, fluoride, or androgen

Combination therapy for myelomatosis

MELPHALAN AND ANTIGENIC TYPE OF BENCE-JONES PROTEINS IN MYELOMA